Calcium Dobesilate Capsules
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20203548
Indications:
1. Treatment of Microangiopathies:
Diabetic microangiopathies (retinopathy and glomerulosclerosis [Kimmelstiel-Wilson syndrome]).
Microvascular injuries associated with increased capillary fragility and permeability, capillary bleeding, and acrocyanosis.
2.Adjunctive Therapy for Chronic Venous Insufficiency (CVI):
Varicose vein syndromes and sequelae (post-thrombotic syndrome, leg ulcers, stasis dermatitis, peripheral edema, etc.).
Administration:
Diabetic Retinopathy: 1 capsule at a time, 3 times a day (morning, noon, evening).
Other Indications: 1 capsule at a a time, 2 times a day (morning and evening). If clinical improvement occurs, omit the evening dose after approximately 1 month.
Specifications:
0.5g × 36 capsules
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.